KoBioLabs, Inc (KOSDAQ:348150)
South Korea · Delayed Price · Currency is KRW 4,955.00
-45.00 (-0.90%)
Last updated: Oct 30, 2025, 9:59 AM KST
KoBioLabs Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Operating Revenue | 69,479 | 68,359 | 33,138 | 11,606 | 2,893 | 4,591 | Upgrade |
Other Revenue | - | - | - | -0 | -0 | - | Upgrade |
| 69,479 | 68,359 | 33,138 | 11,606 | 2,893 | 4,591 | Upgrade | |
Revenue Growth (YoY) | 33.41% | 106.29% | 185.53% | 301.12% | -36.98% | 696.41% | Upgrade |
Cost of Revenue | 18,463 | 21,565 | 9,429 | 3,627 | 995.01 | 1,956 | Upgrade |
Gross Profit | 51,016 | 46,794 | 23,709 | 7,979 | 1,898 | 2,636 | Upgrade |
Selling, General & Admin | 51,830 | 46,134 | 27,321 | 13,675 | 5,580 | 5,894 | Upgrade |
Research & Development | 7,772 | 6,905 | 14,262 | 14,198 | 12,496 | 8,882 | Upgrade |
Amortization of Goodwill & Intangibles | 73.16 | 68.43 | 67.5 | 72.32 | 65.6 | 64.2 | Upgrade |
Other Operating Expenses | 195.27 | 196 | 173.28 | 163.74 | 25.93 | 87.18 | Upgrade |
Operating Expenses | 60,206 | 53,699 | 42,167 | 28,270 | 18,236 | 14,981 | Upgrade |
Operating Income | -9,190 | -6,905 | -18,458 | -20,292 | -16,337 | -12,345 | Upgrade |
Interest Expense | -598.74 | -1,158 | -1,532 | -1,683 | -152.59 | -708.11 | Upgrade |
Interest & Investment Income | 1,980 | 2,408 | 3,253 | 2,135 | 499.93 | 402.93 | Upgrade |
Currency Exchange Gain (Loss) | -1,048 | 1,010 | 653.71 | 36.2 | 113.34 | 242.53 | Upgrade |
Other Non Operating Income (Expenses) | 140.69 | 144.16 | 1,384 | -3,223 | -498.84 | -42,665 | Upgrade |
EBT Excluding Unusual Items | -8,716 | -4,501 | -14,700 | -23,026 | -16,376 | -55,072 | Upgrade |
Gain (Loss) on Sale of Investments | 146.57 | - | - | 11.51 | 7.08 | - | Upgrade |
Gain (Loss) on Sale of Assets | -0.4 | -123.43 | - | -15.41 | 0.26 | - | Upgrade |
Other Unusual Items | - | 447.05 | 16.99 | - | - | - | Upgrade |
Pretax Income | -8,570 | -4,178 | -14,683 | -23,030 | -16,368 | -55,072 | Upgrade |
Income Tax Expense | -19.76 | 439.17 | 475.14 | 355.52 | -986.27 | - | Upgrade |
Earnings From Continuing Operations | -8,550 | -4,617 | -15,158 | -23,386 | -15,382 | -55,072 | Upgrade |
Minority Interest in Earnings | 269.42 | -681.1 | 1,305 | 1,464 | - | - | Upgrade |
Net Income | -8,281 | -5,298 | -13,853 | -21,921 | -15,382 | -55,072 | Upgrade |
Net Income to Common | -8,281 | -5,298 | -13,853 | -21,921 | -15,382 | -55,072 | Upgrade |
Shares Outstanding (Basic) | 19 | 19 | 19 | 17 | 16 | 11 | Upgrade |
Shares Outstanding (Diluted) | 19 | 19 | 19 | 17 | 16 | 11 | Upgrade |
Shares Change (YoY) | 2.38% | 3.54% | 10.30% | 4.68% | 49.69% | 51.75% | Upgrade |
EPS (Basic) | -427.18 | -276.18 | -747.72 | -1305.15 | -958.62 | -5137.55 | Upgrade |
EPS (Diluted) | -427.79 | -276.18 | -748.00 | -1305.15 | -959.00 | -5138.00 | Upgrade |
Free Cash Flow | -6,835 | -5,995 | -28,966 | -31,239 | -17,993 | -12,896 | Upgrade |
Free Cash Flow Per Share | -352.59 | -312.55 | -1563.45 | -1859.88 | -1121.36 | -1202.99 | Upgrade |
Gross Margin | 73.43% | 68.45% | 71.55% | 68.75% | 65.61% | 57.41% | Upgrade |
Operating Margin | -13.23% | -10.10% | -55.70% | -174.84% | -564.66% | -268.87% | Upgrade |
Profit Margin | -11.92% | -7.75% | -41.80% | -188.89% | -531.63% | -1199.45% | Upgrade |
Free Cash Flow Margin | -9.84% | -8.77% | -87.41% | -269.17% | -621.88% | -280.86% | Upgrade |
EBITDA | -6,431 | -4,327 | -16,943 | -19,383 | -16,105 | -12,135 | Upgrade |
EBITDA Margin | -9.25% | -6.33% | -51.13% | -167.02% | - | -264.30% | Upgrade |
D&A For EBITDA | 2,759 | 2,578 | 1,515 | 908.06 | 232.72 | 209.89 | Upgrade |
EBIT | -9,190 | -6,905 | -18,458 | -20,292 | -16,337 | -12,345 | Upgrade |
EBIT Margin | -13.23% | -10.10% | -55.70% | -174.84% | - | -268.87% | Upgrade |
Advertising Expenses | - | 14,172 | 7,806 | 3,478 | 717.8 | - | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.